Clinical Trial Update: Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sublingual misoprostol with oxytocin for the prevention of postpartum hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)
• Oxytocin (Oxytocin)

Snippet

Sponsor: Jawaharlal Nehru Medical College | Conditions: Postpartum Hemorrhage | Phase 3 | Status: COMPLETED